Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Caplin Point Laboratories Limited (NSE: CAPLIPOINT), ISIN INE475E01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CAPLIPOINT last traded at ₹2501.00 (+4.97%), with a 52-week range of ₹1500.30 to ₹2990.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 70.57%, FIIs 5.72%, DIIs 2.20%, mutual funds 1.64%.
EquiSense Score (ECS): 80/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.